3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Thyroid Cancer, Papillary
2
Sarcoma
2
Salivary Gland Neoplasms
2
Brain Neoplasms
2
Wilms Tumor
1
Solid Tumors
1
Sarcoma, Ewing
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Nephroma, Mesoblastic
1
Neoplasm Metastasis
1
Melanoma
1
Medulloblastoma
1
Lymphoma, Large-Cell, Anaplastic
1
Locally Advanced Solid Tumors
1
Head and Neck Neoplasms
1
Glioma
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Cytarabine
7
Daunorubicin
5
Azacitidine
5
venetoclax
3
Decitabine
3
ivosidenib
2
decitabine and cedazuridine drug combination
2
cedazuridine
2
Mitoxantrone
2
Idarubicin
2
Etoposide
2
treosulfan
1
tagraxofusp
1
revumenib
1
quizartinib
1
olutasidenib
1
glasdegib
1
gilteritinib
1
fludarabine
1
etoposide phosphate
1
enasidenib
1
cc-486
1
Midazolam
1
Itraconazole
1
Granulocyte Colony-Stimulating Factor
1
Gemtuzumab
1
Drug Therapy
1
Cobicistat
1
CPX-351
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Leukemia, Myeloid, Acute
×
entrectinib
×
Clear all
No trials found.